MEEDER ASSET MANAGEMENT INC - SUTRO BIOPHARMA INC ownership

SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 121 filers reported holding SUTRO BIOPHARMA INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
MEEDER ASSET MANAGEMENT INC ownership history of SUTRO BIOPHARMA INC
ValueSharesWeighting
Q3 2021$68,000
+21.4%
3,609
+19.8%
0.00%
+33.3%
Q2 2021$56,000
+51.4%
3,013
+85.5%
0.00%
+50.0%
Q1 2021$37,000
-21.3%
1,624
-65.1%
0.00%
-33.3%
Q3 2020$47,000
+147.4%
4,659
+80.6%
0.00%
+200.0%
Q2 2020$19,000
-17.4%
2,580
+15.4%
0.00%
-50.0%
Q1 2020$23,000
+666.7%
2,236
+673.7%
0.00%
Q4 2019$3,0000.0%2890.0%0.00%
Q3 2019$3,0002890.00%
Other shareholders
SUTRO BIOPHARMA INC shareholders Q3 2021
NameSharesValueWeighting ↓
Samsara BioCapital, LLC 1,675,579$5,814,2591.78%
SUVRETTA CAPITAL MANAGEMENT, LLC 5,883,693$20,416,4151.10%
Kynam Capital Management, LP 1,552,675$5,387,7820.88%
Parkman Healthcare Partners LLC 1,182,168$4,102,1230.75%
Rubric Capital Management LP 3,344,810$11,606,4910.44%
BVF INC/IL 3,347,946$11,617,3730.31%
DAFNA Capital Management LLC 283,079$982,2840.31%
SECTORAL ASSET MANAGEMENT INC 432,339$1,500,2160.29%
Eversept Partners, LP 769,638$2,670,6440.23%
Frazier Life Sciences Management, L.P. 780,000$2,706,6000.18%
View complete list of SUTRO BIOPHARMA INC shareholders